Home > Healthcare > Medical Devices > Surgical Devices > Resectoscope Devices Market

Resectoscope Devices Market Size

  • Report ID: GMI12746
  • Published Date: Dec 2024
  • Report Format: PDF

Resectoscope Devices Market Size

The global resectoscope devices market size was valued at USD 402.2 million in 2024 and is expected to exhibit growth at a CAGR of 5.7% from 2025 to 2034 period. The market growth is attributed to the rising prevalence of urological and gynecological disorders and the shift towards minimally invasive procedures.

 

As conditions such as benign prostatic hyperplasia (BPH) and bladder cancer become more prevalent worldwide, the demand for transurethral resection procedures is on the rise. According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), approximately 50% of men aged 51 to 60 experience BPH, further driving the need for such procedures. In these minimally invasive treatments, resectoscopes play a crucial role, delivering precision and shortening recovery times in contrast to conventional surgeries.
 

Resectoscope devices are specialized medical instruments used primarily in urology and gynecology for performing minimally invasive procedures. These devices are equipped with a light source, irrigation system, and electrosurgical devices, enabling precise resection of tissue from the bladder, prostate, or uterus.  

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global resectoscope devices industry was valued at USD 402.2 million in 2024 and is projected to grow at a CAGR of 5.7% from 2025 to 2034, driven by the increasing prevalence of urological and gynecological disorders and the shift towards minimally invasive procedures.

The monopolar resectoscopes segment is expected to reach over USD 327.3 million by 2034, growing at a CAGR of 5.5%, as they are extensively used for transurethral resection of the prostate (TURP) and hysteroscopic surgeries, ensuring effective treatment outcomes.

The U.S. resectoscope devices market was valued at USD 148.7 million in 2024 and is anticipated to grow at a CAGR of 4.9% from 2025 to 2034, supported by the availability of advanced surgical equipment and innovative solutions from leading market players.

Key players in the market include Advin Urology, bissinger, ESC Medicams, ENDOMED SYSTEMS, JDmeditech, KARL STORZ, LEPU MEDICAL, OLYMPUS, Orion Medical, Richard Wolf, Stryker, and TONTARRA.

Resectoscope Devices Market Scope

Buy Now


Premium Report Details

  • Base Year: 2024
  • Companies covered: 12
  • Tables & Figures: 119
  • Countries covered: 19
  • Pages: 135
 Download Free Sample